December 21st 2020
Joseph Kim, MD, on the utility of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
December 15th 2020
Joseph Kim, MD, discusses the multidisciplinary management of hepatocellular carcinoma.
December 1st 2020
Joseph Kim, MD, discusses the evolution of therapy in metastatic hepatocellular carcinoma.
November 25th 2020
Joseph Kim, MD, discusses curative therapeutic options in hepatocellular carcinoma.